Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Arrhythmia and Electrophysiology
Search: search_blue_button Advanced Search
Published Online
on August 25, 2009

Circulation: Arrhythmia and Electrophysiology. 2009
Published online before print August 25, 2009, doi: 10.1161/CIRCEP.109.872309
A more recent version of this article appeared on October 1, 2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2/5/540    most recent
CIRCEP.109.872309v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Vega, A. L.
Right arrow Articles by Makielski, J. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vega, A. L.
Right arrow Articles by Makielski, J. C.
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Clinical genetics
Right arrow Arrythmias-basic studies
Right arrow Functional genomics
Right arrow Ion channels/membrane transport

Original Article

PKA-Dependent Biophysical Phenotype for V227F-KCNJ2 Mutation in Catecholaminergic Polymorphic Ventricular Tachycardia

Amanda L. Vega1; David J. Tester2; Michael J. Ackerman2 and Jonathan C. Makielski3,4

1 University of Wisconsin, Madison, WI & University of Washington, Seattle, WA;
2 Mayo Clinic, Rochester, MN;
3 University of Wisconsin, Madison, WI

* Corresponding author; email: jcm{at}medicine.wisc.edu

BackgroundKCNJ2 encodes Kir2.1, a pore-forming subunit of the cardiac inward rectifier current, IK1. KCNJ2 mutations are associated with Andersen-Tawil syndrome (ATS) and also Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT). The aim of this study was to characterize the biophysical and cellular phenotype of a KCNJ2 missense mutation, V227F, found in a patient with CPVT.

Methods and Results—Kir2.1-wild type (WT) and V227F channels were expressed individually and together in Cos-1 cells to measure IK1 by voltage clamp. Unlike typical ATS-associated KCNJ2 mutations which show dominant negative loss of function, Kir2.1WT+V227F co-expression yielded IK1 indistinguishable from Kir2.1-WT under basal conditions. To simulate catecholamine activity, a PKA-stimulating cocktail comprised of forskolin and 3-isobutyl-1-methylxanthine (IBMX) was used to increase PKA activity. This PKA-simulated catecholaminergic stimulation caused marked reduction of outward IK1 compared to Kir2.1-WT. PKA-induced reduction in IK1 was eliminated by mutating the phosphorylation site at serine 425 (S425N).

Conclusions—Heteromeric Kir2.1-V227F and WT channels showed an unusual latent loss of function biophysical phenotype that depended upon PKA-dependent Kir2.1 phosphorylation. This biophysical phenotype, distinct from typical ATS mutations, suggests a specific mechanism for PKA dependent IK1 dysfunction for this KCNJ2 mutation which correlates with adrenergic conditions underlying the clinical arrhythmia.

Key Words: arrhythmia • catecholamines • ion channels • long-QT syndrome • tachycardia • K-channel • Andersen-Tawil syndrome • catecholaminergic polymorphic ventricular tachycardia